Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.38T | 2.27T | 2.10T | 2.01T | 1.91T |
Gross Profit | 593.13B | 526.68B | 450.44B | 397.92B | 469.74B |
EBITDA | 473.42B | 430.70B | 356.48B | 301.97B | 372.05B |
Net Income | 224.65B | 197.00B | 176.99B | 129.58B | 183.97B |
Balance Sheet | |||||
Total Assets | 9.49T | 8.84T | 8.21T | 7.74T | 7.40T |
Cash, Cash Equivalents and Short-Term Investments | 189.81B | 144.26B | 156.23B | 199.64B | 190.31B |
Total Debt | 4.43T | 4.05T | 3.67T | 3.62T | 3.48T |
Total Liabilities | 6.25T | 5.81T | 5.29T | 5.09T | 4.91T |
Stockholders Equity | 3.11T | 2.90T | 2.80T | 2.56T | 2.41T |
Cash Flow | |||||
Free Cash Flow | 20.86B | -65.04B | 29.90B | -88.47B | -386.72B |
Operating Cash Flow | 241.70B | 297.71B | 271.47B | 187.86B | 87.09B |
Investing Cash Flow | -286.99B | -422.03B | -210.06B | -131.03B | -532.81B |
Financing Cash Flow | 59.99B | 111.45B | -139.60B | -66.56B | 467.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $24.77B | 15.30 | 7.82% | 2.96% | -6.74% | -13.89% | |
70 Outperform | $13.45B | 113.60 | 3.40% | 4.30% | 2.35% | -73.89% | |
67 Neutral | $25.75B | 26.44 | 9.01% | 4.19% | 3.91% | 8.78% | |
65 Neutral | $28.92B | 25.29 | 9.67% | 3.51% | 5.61% | 19.66% | |
63 Neutral | $6.86B | 17.00 | -2.14% | 7.13% | 4.56% | -27.45% | |
61 Neutral | $18.30B | 31.70 | 9.37% | 4.04% | 1.55% | 0.73% | |
60 Neutral | $18.88B | 27.10 | 14.40% | 3.74% | 7.56% | 54.15% |